Enzo Biochem, Inc. To be Acquired by Battery Ventures in All-Cash Transaction Transaction Follows Completion of Comprehensive Strategic Review by Special Committee of the Board to Maximize Shareholder Value Farmingdale, NY, June 24, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) today announced that on June 23, 2025, following the market close, it entered into an Agreement and Plan of Merger (the “Merger Agreement”) to be acquired by Battery Ventures, a global, technology-focused investment firm, through its newly formed entity Bethpage Parent, Inc. ...
Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results FARMINGDALE, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) today announced financial results for the fiscal third quarter ended April 30, 2025. Financial Highlights The Company’s third-quarter revenue of $6.4 million declined by $1.6 million or 20% compared to the same period in the prior year across all geographic areas. This is due to general continued headwinds in the life sciences tools space, including decreases in government grants, reduced R&D budgets, and tariffs unce...
A director at Iovance Biotherapeutics Inc maiden bought 30,000 shares at 1.840USD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...
A director at Tidewater Inc bought 25,000 shares at 42.086USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Autoscope Technologies Corporation Announces Financial Results, Dividend Declaration and 2025 Annual Meeting of Shareholders MINNEAPOLIS, May 08, 2025 (GLOBE NEWSWIRE) -- Autoscope Technologies Corporation (“AATC” or the “Company”) (OTCQX: AATC) today announced results for its quarter ended March 31, 2025. The Board of Directors has authorized and declared a quarterly cash dividend of $0.15 per share of its common stock. The dividend is payable on May 27, 2025 to the shareholders of record at the close of business on May 19, 2025. The Company also announced today that its Board of ...
Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential Transaction Forms Special Committee of the Board to Lead Evaluation of Viable Options for Maximizing Shareholder Value Engages Independent Financial and Legal Advisors to Support Thorough Process Remains Committed to Maintaining Focus on Cost Containment, Cash Preservation and Near-Term Initiatives to Enhance Value Farmingdale, NY, April 22, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) today announced that its Board of Directors ...
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX FARMINGDALE, N.Y., March 28, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced its intention to voluntarily delist its common stock from The New York Stock Exchange (“NYSE”) and to have its common stock quoted on the OTCQX Best Market (“OTCQX”). Enzo provided notice of the voluntary delisting to the NYSE on March 28, 2025 and intends to timely file a notification of removal from listing on ...
Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results FARMINGDALE, N.Y., March 17, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal second quarter ended January 31, 2025, with sequential quarter improvement in revenue, gross margin and operating profit / loss. Financial Highlights The Company’s second-quarter gross margin percentage of 52% increased sequentially from 37% during Q1 2025 and increased from 49% during the second quarter of the prior year. These improvements were driven by change in re...
Autoscope Technologies Corporation Announces Financial Results MINNEAPOLIS, March 17, 2025 (GLOBE NEWSWIRE) -- Autoscope Technologies Corporation (OTCQX: AATC) today announced results for its quarter and year ended December 31, 2024. Fourth Quarter 2024 Financial Summary Royalties increased 22 percent to $3.0 million in the fourth quarter of 2024 compared to $2.5 million in the same period in the prior year.Product sales increased 186 percent to $292,000 in the fourth quarter of 2024 compared to $102,000 in the same period in the prior year.Operating expenses from continuing operati...
Autoscope Technologies Corporation Announces Quarterly Dividend MINNEAPOLIS, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Autoscope Technologies Corporation (“Autoscope”) (OTCQX: AATC) announced today that its Board of Directors has declared a regular quarterly dividend of $0.15 per share of common stock, payable on February 25, 2025 to shareholders of record at the close of business on February 18, 2025. About Autoscope Technologies Corporation Autoscope Technologies Corporation is a global company dedicated to helping improve safety and efficiency for cities and highways by developing and delive...
Autoscope Technologies Corporation Announces 2025 Special Cash Dividend of $1.05 Per Share MINNEAPOLIS, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Autoscope Technologies Corporation (“Autoscope”) (OTCQX: AATC) announced today that its Board of Directors has declared a special one-time cash dividend of $1.05 per share of common stock, payable on February 3, 2025 to shareholders of record at the close of business on January 27, 2025. As a result of the Board's review of the Company's current financial position and business outlook, the Board determined that the payment of a special dividend was in ...
S&P 500, Nasdaq 100 Testing Bull Flag Supports Continued strong economic data has reduced the number of expected Fed rate cuts, which has pushed long-term Treasury bond yields and the U.S. dollar (DXY) above some key levels, putting some pressure on the broad market indexes. The Bloomberg Commodity index (DJP) is breaking above the key $33.25 resistance level, while WTI crude oil is breaking above its 1+ year downtrend. Upside is likely to be capped due to these concerns, but we still continue ...
Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules FARMINGDALE, N.Y, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced that it was notified by the New York Stock Exchange (the “NYSE”) that it is not in compliance with Section 802.01B and Section 802.01C of the NYSE Listed Company Manual because (i) its 30 trading-day average market capitalization was less than $50 million and its last reported stockholder’s equity as of October 31, 2024 was less than $50 million and (ii) the average closing pri...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.